Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 2,722.007 | $200.01 | $544,420.45 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,830.521 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 - $200.07, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 2,906 | $148.07 | $430,291.42 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,552.528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:27 UTC |
keller brettDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-011169 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,874 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:27 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-011170 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,876 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:27 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 141 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-011172 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,300 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:27 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-011171 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,335 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 13:33 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,178 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-23-010924 · doc4.xml · derivative · entry 4 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,178 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 13:33 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
SaleCommon Stock | 3,664 | $189.49 | $694,295.39 |
DisclosureSEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 3 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,480.696 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.4200 - $189.4996, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 13:33 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
SaleCommon Stock | 426 | $189.49 | $80,723.21 |
DisclosureSEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 2 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,144.696 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.4200 - $189.4996, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 13:33 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionCommon Stock | 4,178 | $93.88 | $392,230.64 |
DisclosureSEC source: 0001225208-23-010924 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,570.696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $117.34 | $0.00 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · derivative · entry 6 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,854 Underlying: Common Stock · 10,000 shares Expires 2030-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $117.34 | $0.00 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · derivative · entry 5 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,854 Underlying: Common Stock · 10,000 shares Expires 2030-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 9,065 | $192.43 | $1,744,396.99 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 4 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,646.528 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.56 - $193.61, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 9,026 | $195.21 | $1,761,975.39 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,711.528 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.00 - $195.60, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 10,000 | $117.34 | $1,173,400.00 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,737.528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 21:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 10,000 | $117.34 | $1,173,400.00 |
DisclosureSEC source: 0001225208-23-010602 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,737.528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 17:57 UTC |
KALENKA ROBERT FCorporate Vice President
|
GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010179 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,759.4097 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| November 09, 2023 Filed Nov 9, 2023 21:54 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,151 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-23-010148 · doc4.xml · derivative · entry 3 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,456 Underlying: Common Stock · 4,151 shares Expires 2032-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2023 Filed Nov 9, 2023 21:54 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
SaleCommon Stock | 3,771 | $176.61 | $665,992.92 |
DisclosureSEC source: 0001225208-23-010148 · doc4.xml · nonDerivative · entry 2 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,402.98 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.55 - $176.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 09, 2023 Filed Nov 9, 2023 21:54 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionCommon Stock | 4,151 | $144.84 | $601,230.84 |
DisclosureSEC source: 0001225208-23-010148 · doc4.xml · nonDerivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,173.98 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Duelks Robert NDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010198 · doc4.xml · derivative · entry 3 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010198 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,567 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
FLOWERS MELVIN LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010199 · doc4.xml · derivative · entry 2 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010199 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,676 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
keller brettDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010200 · doc4.xml · derivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
keller brettDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010200 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,719 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 15:20 UTC |
BRUN LESLIE ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,037 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010196 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,037 Underlying: Common Stock · 3,037 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 15:20 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010196 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,279 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
MURRAY EILEEN KDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010202 · doc4.xml · derivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010202 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,721 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Zavery AmitDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010204 · doc4.xml · derivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010204 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,159 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Nazareth Annette L.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010203 · doc4.xml · derivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010203 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Markus Maura A.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010201 · doc4.xml · derivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010201 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,442.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Carter Pamela LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,241 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-23-010197 · doc4.xml · derivative · entry 2 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 2,241 shares Expires 2033-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 20:20 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-010197 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 18:00 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 20,614 | $176.94 | $3,647,480.33 |
DisclosureSEC source: 0001225208-23-010124 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,737.528 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.93 - $178.03, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009419 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,029 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 09:05 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009425 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,061 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009420 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,138 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
keller brettDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009421 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,181 F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
keller brettDirector
|
GrantCommon Stock | 32 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009421 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,169 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 09:05 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009417 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,550 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009423 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,183 F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009423 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,182 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009426 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,621 F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009426 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,611 F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 05, 2023 Filed Oct 10, 2023 13:05 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009424 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,642 F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.